{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T06:39:36Z","timestamp":1763793576126,"version":"3.45.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,21]]},"DOI":"10.7759\/cureus.97476","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T06:37:46Z","timestamp":1763793466000},"source":"Crossref","is-referenced-by-count":0,"title":["Molecular Profiling of KRAS, NRAS, and BRAF in Colorectal Cancer: Insights From a Libyan Cohort"],"prefix":"10.7759","author":[{"given":"Hoda M","family":"Tawel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monira A","family":"Rahuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nada A","family":"Hweissa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2023.101839","article-title":"Colorectal cancer: a health and economic problem","volume":"66","author":"Klimeck L","year":"2023","unstructured":"Klimeck L, Heisser T, Hoffmeister M, Brenner H. Colorectal cancer: a health and economic problem. Best Pract Res Clin Gastroenterol. 2023, 66:101839. 10.1016\/j.bpg.2023.101839","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-327736","article-title":"Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN","volume":"72","author":"Morgan E","year":"2023","unstructured":"Morgan E, Arnold M, Gini A, et al.. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 2023, 72:338-44. 10.1136\/gutjnl-2022-327736","journal-title":"Gut"},{"key":"ref3","unstructured":"Cancer Incidence in Libya 2020. Accessed. September 7, 2025: https:\/\/seha.ly\/media\/studies\/results-of-the-first-comprehensive-report-of-the-national-cancer-registry-2020xPyDoQ4.pdf."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.54361\/LJMR.19.2.06","article-title":"Colorectal carcinoma in Western Libya: a retrospective study on Libyan patients treated at Subrata National Cancer Institute (SNCI)","volume":"19","author":"Draa S","year":"2025","unstructured":"Draa S, Oshkondale F, Abdallaa A, et al.. Colorectal carcinoma in Western Libya: a retrospective study on Libyan patients treated at Subrata National Cancer Institute (SNCI). Libyan J Med Res. 2025, 19:46-59. 10.54361\/LJMR.19.2.06","journal-title":"Libyan J Med Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v6.i4.98","article-title":"Colorectal carcinoma in a Southern Mediterranean country: the Libyan scenario","volume":"6","author":"Bodalal Z","year":"2014","unstructured":"Bodalal Z, Bendardaf R. Colorectal carcinoma in a Southern Mediterranean country: the Libyan scenario. World J Gastrointest Oncol. 2014, 6:98-103. 10.4251\/wjgo.v6.i4.98","journal-title":"World J Gastrointest Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/or.2024.1449709","article-title":"Colorectal cancer and associated genetic, lifestyle, cigarette, nargileh-hookah use and alcohol consumption risk factors: a comprehensive case-control study","volume":"18","author":"Bener A","year":"2024","unstructured":"Bener A, \u00d6zt\u00fcrk AE, Dasdelen MF, et al.. Colorectal cancer and associated genetic, lifestyle, cigarette, nargileh-hookah use and alcohol consumption risk factors: a comprehensive case-control study. Oncol Rev. 2024, 18:1449709. 10.3389\/or.2024.1449709","journal-title":"Oncol Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajcnut.2025.01.014","article-title":"Dietary-lifestyle patterns and colorectal cancer risk: Global Cancer Update Programme (CUP Global) systematic literature review","volume":"121","author":"Chu AH","year":"2025","unstructured":"Chu AH, Lin K, Croker H, et al.. Dietary-lifestyle patterns and colorectal cancer risk: Global Cancer Update Programme (CUP Global) systematic literature review. Am J Clin Nutr. 2025, 121:986-98. 10.1016\/j.ajcnut.2025.01.014","journal-title":"Am J Clin Nutr"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.01.054","article-title":"Hereditary and familial colon cancer","volume":"138","author":"Jasperson KW","year":"2010","unstructured":"Jasperson KW, Tuohy TM, Neklason DW, Burt RW. Hereditary and familial colon cancer. Gastroenterology. 2010, 138:2044-58. 10.1053\/j.gastro.2010.01.054","journal-title":"Gastroenterology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2022.23.11.3725","article-title":"Clinical significance of somatic mutations in RAS\/RAF\/MAPK signaling pathway in Moroccan and North African colorectal cancer patients","volume":"23","author":"Benmokhtar S","year":"2022","unstructured":"Benmokhtar S, Laraqui A, El Boukhrissi F, et al.. Clinical significance of somatic mutations in RAS\/RAF\/MAPK signaling pathway in Moroccan and North African colorectal cancer patients. Asian Pac J Cancer Prev. 2022, 23:3725-33. 10.31557\/APJCP.2022.23.11.3725","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/medicina61030408","article-title":"A narrative review of RAS mutations in early-stage colorectal cancer: mechanisms and clinical implications","volume":"61","author":"Yildirim HC","year":"2025","unstructured":"Yildirim HC, Gunenc D, Almuradova E, Sutcuoglu O, Yalcin S. A narrative review of RAS mutations in early-stage colorectal cancer: mechanisms and clinical implications. Medicina (Kaunas). 2025, 61:408. 10.3390\/medicina61030408","journal-title":"Medicina (Kaunas)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.06.009","article-title":"RAS proteins and their regulators in human disease","volume":"170","author":"Simanshu DK","year":"2017","unstructured":"Simanshu DK, Nissley DV, McCormick F. RAS proteins and their regulators in human disease. Cell. 2017, 170:17-33. 10.1016\/j.cell.2017.06.009","journal-title":"Cell"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2021.2359","article-title":"KRAS mutations in patients with colorectal cancer in Libya","volume":"15","author":"Abudabous A","year":"2021","unstructured":"Abudabous A, Drah M, Aldehmani M, Parker I, Alqawi O. KRAS mutations in patients with colorectal cancer in Libya. Mol Clin Oncol. 2021, 15:197. 10.3892\/mco.2021.2359","journal-title":"Mol Clin Oncol"},{"key":"ref13","article-title":"Prognostic significance of KRAS gene mutations in colorectal cancer--preliminary study","volume":"7","author":"Dinu D","year":"2014","unstructured":"Dinu D, Dobre M, Panaitescu E, et al.. Prognostic significance of KRAS gene mutations in colorectal cancer--preliminary study. J Med Life. 2014, 7:581-7.","journal-title":"J Med Life"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/PDM.0b013e3181c93fd1","article-title":"NRAS mutations are rare in colorectal cancer","volume":"19","author":"Irahara N","year":"2010","unstructured":"Irahara N, Baba Y, Nosho K, et al.. NRAS mutations are rare in colorectal cancer. Diagn Mol Pathol. 2010, 19:157-63. 10.1097\/PDM.0b013e3181c93fd1","journal-title":"Diagn Mol Pathol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/cells13141221","article-title":"KRAS mutation subtypes and their association with other driver mutations in oncogenic pathways","volume":"13","author":"Mondal K","year":"2024","unstructured":"Mondal K, Posa MK, Shenoy RP, Roychoudhury S. KRAS mutation subtypes and their association with other driver mutations in oncogenic pathways. Cells. 2024, 13:1221. 10.3390\/cells13141221","journal-title":"Cells"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-11600-z","article-title":"Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis","volume":"23","author":"Lu X","year":"2023","unstructured":"Lu X, Li Y, Li Y, et al.. Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis. BMC Cancer. 2023, 23:1117. 10.1186\/s12885-023-11600-z","journal-title":"BMC Cancer"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1557609","article-title":"Navigating beyond the surface - prognostic significance of KRAS, NRAS, BRAF, PIK3CA, and TP53 mutations examined by exons","volume":"15","author":"Afr\u0103s\u00e2nie VA","year":"2025","unstructured":"Afr\u0103s\u00e2nie VA, Marinca MV, Gafton B, et al.. Navigating beyond the surface - prognostic significance of KRAS, NRAS, BRAF, PIK3CA, and TP53 mutations examined by exons. Front Oncol. 2025, 15:1557609. 10.3389\/fonc.2025.1557609","journal-title":"Front Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1177\/10732748241229290","article-title":"RAS mutations predict recurrence-free survival and recurrence patterns in colon cancer: a unicenter study in Morocco","volume":"31","author":"El Agy F","year":"2024","unstructured":"El Agy F, El Bardai S, Boukansa S, et al.. RAS mutations predict recurrence-free survival and recurrence patterns in colon cancer: a unicenter study in Morocco. Cancer Control. 2024, 31:10732748241229290. 10.1177\/10732748241229290","journal-title":"Cancer Control"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-2612","article-title":"A comprehensive survey of Ras mutations in cancer","volume":"72","author":"Prior IA","year":"2012","unstructured":"Prior IA, Lewis PD, Mattos C. A comprehensive survey of Ras mutations in cancer. Cancer Res. 2012, 72:2457-67. 10.1158\/0008-5472.CAN-11-2612","journal-title":"Cancer Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1126\/science.1260825","article-title":"Variation in cancer risk among tissues can be explained by the number of stem cell divisions","volume":"347","author":"Tomasetti C","year":"2015","unstructured":"Tomasetti C, Vogelstein B. Variation in cancer risk among tissues can be explained by the number of stem cell divisions. Science. 2015, 347:78-81. 10.1126\/science.1260825","journal-title":"Science"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3497","article-title":"How ageing processes influence cancer","volume":"13","author":"de Magalh\u00e3es JP","year":"2013","unstructured":"de Magalh\u00e3es JP. How ageing processes influence cancer. Nat Rev Cancer. 2013, 13:357-65. 10.1038\/nrc3497","journal-title":"Nat Rev Cancer"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2006.02549.x","article-title":"Classification of colorectal cancer based on correlation of clinical, morphological and molecular features","volume":"50","author":"Jass JR","year":"2007","unstructured":"Jass JR. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology. 2007, 50:113-30. 10.1111\/j.1365-2559.2006.02549.x","journal-title":"Histopathology"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21239001","article-title":"The role of BRAF in metastatic colorectal carcinoma-past, present, and future","volume":"21","author":"Djanani A","year":"2020","unstructured":"Djanani A, Eller S, \u00d6fner D, Troppmair J, Maglione M. The role of BRAF in metastatic colorectal carcinoma-past, present, and future. Int J Mol Sci. 2020, 21:9001. 10.3390\/ijms21239001","journal-title":"Int J Mol Sci"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu275","article-title":"Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features","volume":"25","author":"Missiaglia E","year":"2014","unstructured":"Missiaglia E, Jacobs B, D'Ario G, et al.. Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features. Ann Oncol. 2014, 25:1995-2001. 10.1093\/annonc\/mdu275","journal-title":"Ann Oncol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.27.4860","article-title":"Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study","volume":"28","author":"Douillard JY","year":"2010","unstructured":"Douillard JY, Siena S, Cassidy J, et al.. Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study. J Clin Oncol. 2010, 28:4697-705. 10.1200\/JCO.2009.27.4860","journal-title":"J Clin Oncol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0805019","article-title":"Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer","volume":"360","author":"Van Cutsem E","year":"2009","unstructured":"Van Cutsem E, K\u00f6hne CH, Hitre E, et al.. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med. 2009, 360:1408-17. 10.1056\/NEJMoa0805019","journal-title":"N Engl J Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908075","article-title":"Encorafenib, binimetinib, and cetuximab in BRAF V600E-mutated colorectal cancer","volume":"381","author":"Kopetz S","year":"2019","unstructured":"Kopetz S, Grothey A, Yaeger R, et al.. Encorafenib, binimetinib, and cetuximab in BRAF V600E-mutated colorectal cancer. N Engl J Med. 2019, 381:1632-43. 10.1056\/NEJMoa1908075","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/428467-molecular-profiling-of-kras-nras-and-braf-in-colorectal-cancer-insights-from-a-libyan-cohort","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T06:37:46Z","timestamp":1763793466000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/428467-molecular-profiling-of-kras-nras-and-braf-in-colorectal-cancer-insights-from-a-libyan-cohort"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.97476","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,21]]}}}